We are interested in innovative projects in early stage development, particularly in the following areas:
-
Diagnostics: Molecular diagnostics (genetic testing and sequencing), POCT, Innovative diagnostic platforms for central laboratories and reference laboratories
-
Antibody-based drugs
-
Cell therapy and gene therapy, especially CAR-T
We mainly focus on Angel stage investment and early stage venture with the amount of single investment to be USD 100 thousand-5 million.
